CRISPR Therapeutics (NASDAQ:CRSP) CEO Samarth Kulkarni Sells 30,000 Shares of Stock

CRISPR Therapeutics (NASDAQ:CRSP) CEO Samarth Kulkarni Sells 30,000 Shares of Stock

CRISPR Therapeutics AG (NASDAQ:CRSP - Get Free Report) CEO Samarth Kulkarni sold 30,000 shares of the business's stock in a transaction dated Tuesday, January 20th. The shares were sold at an average price of $51.75, for a total value of $1,552,500.00. Following the completion of the transaction, the chief executive officer owned 194,201 shares in the company, valued at $10,049,901.75. The trade was a 13.38% decrease in their ownership of the st…

CRISPR Therapeutics stock drops 9% after CEO sale filing — what CRSP investors watch next week

NEW YORK, Jan 24, 2026, 05:05 EST — Market closed CRISPR Therapeutics AG shares dropped 8.7% on Friday, ending the day at $55.52. The stock moved sharply between $61.01 and $55.07 during a choppy session that saw roughly 2.4 million shares change hands. This shift is significant since CRSP is acting like a story stock despite having a tangible product available, leaving little room for uncertainty. When trading turns volatile, even minor headlin…